Demo Sign up Log In

Bristol Myers Squibb (BMY)

R&D Expenses

$2.96B

Quarterly · Period ending: Jun 30, 2026 · USD

BMY R&D Expenses

Latest reported$2.96Bperiod endingJun 30, 2026

Latest reported$2.96Bperiod endingJun 30, 2026

BMY Quarterly R&D Expenses ($0.00 → $2.96B)

Quarterly R&D Expenses

High-resolution chart · PNG

BMY r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	495,000,000
Mar 31, 2001	508,000,000
Dec 31, 2000	564,000,000
Sep 30, 2000	479,000,000
Jun 30, 2000	472,000,000
Mar 31, 2000	446,000,000
Dec 31, 1999	515,000,000
Sep 30, 1999	431,000,000
Jun 30, 1999	453,000,000
Mar 31, 1999	423,000,000
Dec 31, 1998	412,000,000
Sep 30, 1998	398,000,000
Jun 30, 1998	384,000,000
Mar 31, 1998	383,000,000
Dec 31, 1997	392,000,000
Sep 30, 1997	346,000,000
Jun 30, 1997	321,000,000
Mar 31, 1997	326,000,000
Dec 31, 1996	328,000,000
Sep 30, 1996	336,000,000
Jun 30, 1996	309,000,000
Mar 31, 1996	302,000,000
Dec 31, 1995	323,000,000
Sep 30, 1995	293,000,000
Jun 30, 1995	294,000,000
Mar 31, 1995	290,000,000
Dec 31, 1994	302,000,000
Sep 30, 1994	274,000,000
Jun 30, 1994	271,000,000
Mar 31, 1994	261,000,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.